- Report
- February 2024
- 279 Pages
Saudi Arabia
From €1290EUR$1,418USD£1,096GBP
€1720EUR$1,890USD£1,461GBP
- Report
- May 2023
- 526 Pages
Global
From €3800EUR$4,175USD£3,228GBP
- Report
- January 2021
China
From €1993EUR$2,190USD£1,693GBP
- Training
- 90 Minutes
Canada, United States, ... Canada, United States, Europe
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global
From €3186EUR$3,500USD£2,706GBP
- Report
- July 2024
- 96 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- February 2024
- 155 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- February 2022
- 84 Pages
Global
From €3200EUR$3,766USD£2,813GBP
- Report
- May 2022
Middle East, Africa, ... Middle East, Africa, North America, Europe, Asia Pacific, Latin America
From €13197EUR$14,500USD£11,209GBP
- Report
- October 2023
- 391 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP

The In Vitro Diagnostic Device (IVD) market is a segment of the In Vitro Diagnostics (IVD) industry. IVD devices are used to detect, diagnose, and monitor diseases and other medical conditions. These devices are used in laboratories, hospitals, and other healthcare settings. IVD devices include instruments, reagents, and software used to analyze samples such as blood, urine, and tissue.
IVD devices are used to detect a wide range of diseases, including cancer, cardiovascular disease, diabetes, and infectious diseases. They are also used to monitor the effectiveness of treatments and to assess the risk of developing certain diseases.
IVD devices are developed and manufactured by a variety of companies, including Abbott, Becton Dickinson, Roche, Siemens, and Thermo Fisher Scientific. These companies provide a range of products, including instruments, reagents, and software. They also provide services such as training and technical support. Show Less Read more